Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
PHASE2
Diabetic Retinopathy (DR) is a common eye condition caused by diabetes, whe...
Status
Recruiting
Location
Retinal Consultants Of Arizona - Phoenix - North /ID# 283407
RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME)
PHASE2
ABBV-RGX-314 is being developed as a novel, potential one-time gene therapy...
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
PHASE3
Neovascular age-related macular degeneration (nAMD), also known as "wet" AM...